BSECompany Update2 Nov 2026 · 2 Nov 2026, 02:23 pm

The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting "India orders Sun Pharma to halt eye-care drug production at plant after quality lapses" .<BR><BR>The reply is awaited.

Sun Pharmaceutical Industries Ltd · 524715

✦ AI Summary▼ NegativeRegulatory

The BSE has sought clarification from Sun Pharmaceutical Industries Ltd regarding news reports of quality lapses at one of its plants, specifically regarding the production of eye-care drugs.

Analysis Scores

Earnings Impact3/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sun Pharmaceutical Industries Ltd - 524715 - Clarification Sought From Sun Pharmaceutical Industries Ltd